Yakin Splendour Global Holding Berhad is a biotechnology research and investment holding company that focuses on the exploration, discovery, development, cultivation, and application of regenerative medication, immunotherapy, and stem cell treatments. Committed to good health, Yakin Splendour aims to improve access and affordability to create healthier communities and put a healthy mind, body, and environment within everyone's reach. The company believes in overcoming the characteristics of aging and providing scientifically proven preventive medical alternatives rather than individual treatments for specific diseases.

Yakin Splendour strives to be the leader in preventive healthcare services, specializing in regenerative medicine and immunotherapy. They offer a range of products and services, including cell-based medical treatments as alternatives for patients suffering from cancer, aging, antiviral, and diabetic disease-based symptoms. They also provide customizable medical insurance plans and programs, systems enablement and AI applications development, health management and clinical services, and intellectual property rights and licensing.

With a dedicated team of experts and strategic partners, Yakin Splendour is committed to providing preventive, regenerative, and restorative therapies and services to facilitate longer living and healthier lifestyles